Touchstone Mid Cap Value Fund Class A (TCVAX) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
Beta 0.76: the stock has moved about 24% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerTouchstone Mid Cap Value Fund Class A (TCVAX) trades at $26.37. Sector: Financials.
Price as of · Last analyzed: Jun 15, 2026Analyst Coverage for TCVAX: TCVAX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
Touchstone Mid Cap Value Fund Class A (TCVAX) Financial Services Profile
Touchstone Mid Cap Value Fund Class A (TCVAX) is an actively managed mutual fund primarily investing at least 80% of its net assets in common stocks of U.S. mid-capitalization companies, defined by the Russell Midcap® Index. The fund maintains a concentrated portfolio of 60-80 securities, aiming for long-term capital appreciation by identifying undervalued mid-sized firms within the financial services sector.
What Is the Investment Thesis for TCVAX?
Touchstone Mid Cap Value Fund Class A (TCVAX) presents an investment vehicle focused on the mid-capitalization value segment, characterized by its mandate to invest at least 80% of net assets in companies within the Russell Midcap® Index range. With a market capitalization of $0.57 billion and a Beta of 0.76, the fund demonstrates a moderate scale and lower volatility compared to the broader market. The concentrated portfolio of 60-80 securities signifies a high-conviction, actively managed approach, seeking to outperform by identifying undervalued companies. Growth catalysts include sustained investor interest in value-oriented strategies, particularly within the mid-cap space, and the fund's ability to consistently deliver strong relative performance against its benchmark. The diversified holdings across various sectors within the mid-cap universe offer a degree of risk mitigation. However, potential risks include underperformance during periods of strong growth stock outperformance and sensitivity to market sentiment shifts away from value investing. Investors should critically assess the fund's expense ratio and its long-term performance relative to the Russell Midcap Value Index.
Based on FMP financials and quantitative analysis
TCVAX Key Highlights
Market Capitalization: $0.57 billion, reflecting its scale within the asset management industry.
- Beta: 0.76, indicating lower volatility relative to the broader market, suggesting a more stable performance profile.
- Dividend Yield: None, as the fund's primary objective is long-term capital appreciation rather than income distribution.
- Investment Mandate: Commits a minimum of 80% of its net assets to common shares of U.S. mid-capitalization companies.
- Portfolio Concentration: Maintains a focused portfolio of approximately 60 to 80 securities, indicating a high-conviction investment strategy.
Who Are TCVAX's Competitors?
TCVAX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BLK BlackRock, Inc. | $1052.65 | -0.66% | $164B | 51 5-pillar |
| BX Blackstone Inc. | $109.56 | -1.96% | $135B | 68 5-pillar |
| APOS Apollo Global Management, Inc. | $25.57 | -0.08% | $74.8B | 56 5-pillar |
| BAM Brookfield Asset Management | $44.39 | -1.03% | $71.6B | 57 5-pillar |
| AMP Ameriprise Financial, Inc. | $491.77 | +0.18% | $44.1B | 77 5-pillar |
| ARES Ares Management Corporation | $116.55 | -0.85% | $38.5B | 57 5-pillar |
| TROW T. Rowe Price Group, Inc. | $102.67 | -1.87% | $22.4B | 80 5-pillar |
| ATHS Athene Holding Ltd. | $23.41 | -0.43% | $18.8B | 56 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are TCVAX's Key Strengths?
Clear investment mandate focusing on mid-cap value, appealing to specific investor preferences.
- Concentrated portfolio of 60-80 securities allows for high-conviction investing.
- Lower Beta (0.76) suggests potentially lower volatility compared to the overall market.
- Diversified holdings across various sectors within the mid-cap universe can mitigate specific industry risks.
What Are TCVAX's Weaknesses?
Performance is susceptible to underperformance during periods when growth stocks are favored over value.
- Reliance on the Russell Midcap® Index for company definition means its universe shifts with market conditions.
- As an actively managed fund, it faces scrutiny regarding its expense ratio relative to passive alternatives.
- Concentrated portfolio, while high-conviction, could lead to higher idiosyncratic risk if a few holdings underperform significantly.
What Are the Key Risks for TCVAX?
Prolonged underperformance of value stocks relative to growth stocks, leading to investor dissatisfaction and potential redemptions.
- Significant economic downturns or recessions that disproportionately impact mid-capitalization companies, affecting portfolio valuations.
- Higher-than-average expense ratio compared to passive alternatives, which could erode net returns for investors over time.
- Key personnel changes within the portfolio management team, potentially impacting the consistency of the fund's investment strategy and performance.
What Threats Does TCVAX Face?
- Potential: Sustained outperformance of growth stocks could lead to investor outflows from value funds.
- Potential: Increased competition from lower-cost passive mid-cap value ETFs and index funds.
- Ongoing: Adverse changes in market conditions or economic downturns impacting mid-capitalization companies.
- Ongoing: Regulatory changes in the asset management industry that could affect operational costs or investment strategies.
What Are TCVAX's Competitive Advantages?
- **Investment Process and Expertise**: A disciplined, proven investment methodology for identifying undervalued mid-cap companies, coupled with the experience of its portfolio management team.
- **Brand Reputation**: Part of Touchstone Investments, which may leverage a broader brand recognition and trust within the financial services industry.
- **Distribution Network**: Established relationships with financial advisors and institutional consultants who recommend the fund to their clients.
What Does TCVAX Do?
Touchstone Mid Cap Value Fund Class A (TCVAX) operates as a mutual fund within the financial services sector, specifically focusing on asset management. The fund's core strategy involves committing a substantial portion—a minimum of 80% of its net assets, which may include capital acquired through borrowing for investment purposes—to the common shares of companies characterized by medium market capitalizations. This definition of a mid-capitalization company is dynamically linked to the current range represented by the Russell Midcap® Index at the time of purchase, acknowledging that market capitalization parameters are not static but evolve with prevailing market conditions. The fund's approach is rooted in value investing principles, seeking out mid-sized companies that are believed to be undervalued by the market. This strategy aims to capitalize on potential price appreciation as the market recognizes the intrinsic worth of these companies. The portfolio management team typically constructs a concentrated holding, generally comprising approximately 60 to 80 securities. This focused approach suggests a high-conviction strategy, where each holding is expected to contribute significantly to the fund's overall performance. Headquartered in Cincinnati, US, Touchstone Mid Cap Value Fund Class A is part of the broader Touchstone Investments family, offering investors exposure to a specific segment of the equity market with a distinct investment philosophy. The fund's performance is inherently tied to the health and investor sentiment surrounding the mid-cap value segment, presenting both opportunities during favorable market conditions for value stocks and potential challenges during periods when growth stocks are predominantly favored.
What Products and Services Does TCVAX Offer?
- Invests a minimum of 80% of its net assets in common shares of mid-capitalization companies.
- Defines mid-capitalization companies based on the current market value range of the Russell Midcap® Index.
- Employs a value-oriented investment strategy, seeking companies believed to be undervalued by the market.
- Maintains a concentrated portfolio, typically holding between 60 and 80 securities.
- Aims for long-term capital appreciation for its investors.
- Operates as an actively managed mutual fund within the financial services sector.
How Does TCVAX Make Money?
- Generates revenue primarily through management fees charged as a percentage of assets under management (AUM).
- Fees cover the costs of portfolio management, research, administration, and distribution.
- Success is tied to attracting and retaining investor capital, leading to higher AUM and corresponding fee income.
What Industry Does TCVAX Operate In?
Touchstone Mid Cap Value Fund Class A operates within the highly competitive Asset Management industry, a sub-sector of Financial Services. This industry is characterized by firms managing investment portfolios for clients, aiming to generate returns through various strategies. TCVAX specifically targets the mid-capitalization value segment, a niche that seeks companies with solid fundamentals trading below their intrinsic value. The broader asset management market is influenced by economic cycles, interest rate environments, and investor risk appetite. Currently, there's an ongoing debate between growth and value investing, with market sentiment often oscillating between the two. Funds like TCVAX compete not only on performance but also on expense ratios, brand reputation, and distribution channels. Its positioning within the mid-cap value space means its performance is closely tied to the health and investor sentiment towards this specific market segment, which can offer diversification benefits but also unique challenges compared to large-cap or small-cap strategies.
Who Are TCVAX's Key Customers?
- Individual investors seeking exposure to mid-cap value equities, often through financial advisors.
- Institutional investors, such as pension funds, endowments, and foundations.
- Investment platforms and brokerage firms that offer the fund to their client base.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is a fund, not an operating company
TCVAX Financials
Bull Case vs Bear Case
Bull Case
- Clear investment mandate focusing on mid-cap value, appealing to specific investor preferences.
- Concentrated portfolio of 60-80 securities allows for high-conviction investing.
- Lower Beta (0.76) suggests potentially lower volatility compared to the overall market.
- Diversified holdings across various sectors within the mid-cap universe can mitigate specific industry risks.
Bear Case
- Performance is susceptible to underperformance during periods when growth stocks are favored over value.
- Reliance on the Russell Midcap® Index for company definition means its universe shifts with market conditions.
- As an actively managed fund, it faces scrutiny regarding its expense ratio relative to passive alternatives.
- Concentrated portfolio, while high-conviction, could lead to higher idiosyncratic risk if a few holdings underperform significantly.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026
TCVAX Latest News
No recent news available for TCVAX.
TCVAX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for TCVAX.
Price Targets
Wall Street price target analysis for TCVAX.
TCVAX MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for TCVAX; grades run from A+ (80-100) to F (below 30).
TCVAX Financials Stock FAQ
How sensitive is TCVAX to market conditions and investment styles?
TCVAX, as a mid-cap value fund, is highly sensitive to prevailing market conditions and shifts in investment styles. Its performance is closely tied to the overall health and investor sentiment towards the mid-capitalization segment of the market.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Financial metrics are limited to Market Cap, Beta, and Dividend Yield as provided in the source data.